Oral Delivery of Hydrophilic Drugs to the Brain

Aikaterini Lalatsa (Inventor)

Research output: Patent


A composition comprising a lipophilic derivative of a hydrophilic drug and an amphiphile compound for use in therapy wherein the composition is orally administered to the human or animal body. The invention includes derivatives such as palmitoylated Leucine[5]-Enkephalin and is useful in the treatment of schizophrenia, obsesity, pain and sleep disorders, psychiatric diseases, neurodegenerative conditions, brain cancers and infective diseases.
Original languageEnglish
Patent numberWO/2010/100479
IPCA61K 47/18 (2006.01), A61K 47/36 (2006.01), A61K 47/48 (2006.01)
Publication statusPublished - 10 Sept 2010


Dive into the research topics of 'Oral Delivery of Hydrophilic Drugs to the Brain'. Together they form a unique fingerprint.

Cite this